Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Prognostic Impact of Serum β[sub.2]-Microglobulin Levels in Hodgkin Lymphoma Treated with ABVD or Equivalent Regimens: A Comprehensive Analysis of 915 PatientsCancers, 2024-01, Vol.16 (2) [Peer Reviewed Journal]COPYRIGHT 2024 MDPI AG ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers16020238Full text available |
|
2 |
Material Type: Article
|
Comment on Golčić et al. Evaluation of Systemic Treatment Options for Gastrointestinal Stromal Tumours. ICancers/I 2023, I15/I, 4081Cancers, 2023-11, Vol.15 (23) [Peer Reviewed Journal]COPYRIGHT 2023 MDPI AG ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15235618Full text available |
|
3 |
Material Type: Article
|
Correlations between [[sup.68]Ga]Ga-DOTA-TOC Uptake and Absorbed Dose from [[sup.177]Lu]Lu-DOTA-TATECancers, 2023-02, Vol.15 (4) [Peer Reviewed Journal]COPYRIGHT 2023 MDPI AG ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15041134Full text available |
|
4 |
Material Type: Article
|
Potential Therapeutic Improvements in Prostate Cancer Treatment Using Pencil Beam Scanning Proton Therapy with LET[sub.d] Optimization and Disease-Specific RBE ModelsCancers, 2024-02, Vol.16 (4) [Peer Reviewed Journal]COPYRIGHT 2024 MDPI AG ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers16040780Full text available |
|
5 |
Material Type: Article
|
Correction: Zhang et al. Clinical Management of Low Anterior Resection Syndrome: Review of the Current Diagnosis and Treatment. ICancers/I 2023, I15/I, 5011Cancers, 2024-01, Vol.16 (2) [Peer Reviewed Journal]COPYRIGHT 2024 MDPI AG ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers16020459Full text available |
|
6 |
Material Type: Article
|
New IN/I-Adducts of Thiadiazole and Thiazoline with Levoglucosenone and Evaluation of Their Significant Cytotoxic ActivityCancers, 2024-01, Vol.16 (1) [Peer Reviewed Journal]COPYRIGHT 2024 MDPI AG ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers16010216Full text available |
|
7 |
Material Type: Article
|
Epidemiology of Neuroendocrine Neoplasms and Results of Their Treatment with [[sup.177]Lu]Lu-DOTA-TATE or [[sup.177]Lu]Lu-DOTA-TATE and [[sup.90]Y]Y-DOTA-TATE—A Six-Year Experience in High-Reference Polish Neuroendocrine Neoplasm CenterCancers, 2023-11, Vol.15 (22) [Peer Reviewed Journal]COPYRIGHT 2023 MDPI AG ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15225466Full text available |
|
8 |
Material Type: Article
|
Correction: Gubič et al. Design of New Potent and Selective Thiophene-Based K[sub.V]1.3 Inhibitors and Their Potential for Anticancer Activity. ICancers/I 2022, I14/I, 2595Cancers, 2023-05, Vol.15 (11) [Peer Reviewed Journal]COPYRIGHT 2023 MDPI AG ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15112925Full text available |
|
9 |
Material Type: Article
|
Preoperative Dose-Escalated Intensity-Modulated Radiotherapy in Patients with Retroperitoneal Soft-Tissue Sarcoma: Final Results of a Clinical Phase I/II TrialCancers, 2023-05, Vol.15 (10) [Peer Reviewed Journal]COPYRIGHT 2023 MDPI AG ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15102747Full text available |
|
10 |
Material Type: Article
|
Stereotactic Body Radiation Therapy in Hepatocellular Carcinoma and CholangiocarcinomaCancers, 2022-12, Vol.15 (1) [Peer Reviewed Journal]COPYRIGHT 2022 MDPI AG ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15010050Full text available |
|
11 |
Material Type: Article
|
The Current Role of Stereotactic Body Radiation TherapyCancers, 2022-09, Vol.14 (18) [Peer Reviewed Journal]COPYRIGHT 2022 MDPI AG ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers14184383Full text available |
|
12 |
Material Type: Article
|
‘The Reports of My Death Are Greatly Exaggerated’—Evaluating the Effect of Necrosis on IMGMT/I Promoter Methylation Testing in High-Grade GliomaCancers, 2024-05, Vol.16 (10) [Peer Reviewed Journal]COPYRIGHT 2024 MDPI AG ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers16101906Full text available |
|
13 |
Material Type: Article
|
RETRACTED: Godugu et al. Anti-Cancer Activities of Thyrointegrin α[sub.v]β[sub.3] Antagonist Mono- and Bis-Triazole Tetraiodothyroacetic Acid Conjugated via Polyethylene Glycols in Glioblastoma. ICancers/I 2021, I13/I, 2780Cancers, 2024-05, Vol.16 (10) [Peer Reviewed Journal]COPYRIGHT 2024 MDPI AG ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers16101880Full text available |
|
14 |
Material Type: Article
|
Clinical [[sup.18]F]FSPG Positron Emission Tomography Imaging Reveals Heterogeneity in Tumor-Associated System x[sub.c][sup.−] ActivityCancers, 2024-04, Vol.16 (7) [Peer Reviewed Journal]COPYRIGHT 2024 MDPI AG ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers16071437Full text available |
|
15 |
Material Type: Article
|
RETRACTED: Liu et al. Prediction of Ovarian Cancer Response to Therapy Based on Deep Learning Analysis of Histopathology Images. ICancers/I 2023, I15/I, 4044Cancers, 2024-01, Vol.16 (3) [Peer Reviewed Journal]COPYRIGHT 2024 MDPI AG ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers16030493Full text available |
|
16 |
Material Type: Article
|
The m[sup.7]G Reader NCBP2 Promotes Pancreatic Cancer Progression by Upregulating MAPK/ERK SignalingCancers, 2023-11, Vol.15 (22) [Peer Reviewed Journal]COPYRIGHT 2023 MDPI AG ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15225454Full text available |
|
17 |
Material Type: Article
|
Reply to Chen, A.; Zhang, X. Comment on “Golčić et al. Evaluation of Systemic Treatment Options for Gastrointestinal Stromal Tumours. ICancers/I 2023, I15/I, 4081”Cancers, 2023-11, Vol.15 (23) [Peer Reviewed Journal]COPYRIGHT 2023 MDPI AG ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15235619Full text available |
|
18 |
Material Type: Article
|
Integrins Can Act as Suppressors of Ras-Mediated Oncogenesis in the IDrosophila/I Wing Disc EpitheliumCancers, 2023-11, Vol.15 (22) [Peer Reviewed Journal]COPYRIGHT 2023 MDPI AG ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15225432Full text available |
|
19 |
Material Type: Article
|
MitoTam-01 Trial: Mitochondrial Targeting as Plausible Approach to Cancer Therapy. Comment on Yap et al. Complex I Inhibitor of Oxidative Phosphorylation in Advanced Solid Tumors and Acute Myeloid Leukemia: Phase I Trials. INat. Med./I 2023, I29/I, 115–126Cancers, 2023-09, Vol.15 (18) [Peer Reviewed Journal]COPYRIGHT 2023 MDPI AG ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15184476Full text available |
|
20 |
Material Type: Article
|
Targeting IMET/I Amplification: Opportunities and Obstacles in Therapeutic ApproachesCancers, 2023-09, Vol.15 (18) [Peer Reviewed Journal]COPYRIGHT 2023 MDPI AG ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15184552Full text available |